Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection

Journal of Virological Methods

Volumn 161, Issue 2, 2009, Pages 297-304

  Ali, Ayub ^a   Realegeno, Susan ^a   Yang, Otto O ^a   Lewis, Martha J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD4; HIV 1; MHC I; Nef

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS PATHOGENESIS;

ANTIGENS, CD4; CELL LINE; DOWN-REGULATION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIROLOGY; VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 68949166053     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.07.006     Document Type: Article

References (47)

1. Anon. Calcium phosphate transfection. In: Ausubel F., Brent R., Kingston R., Moore D., Seidman J., Smith J., and Struhl K. (Eds). Short Protocols in Molecular Biology vol. 1 (2002), Wiley 9.6-9.7
2. Adnan S., Balamurugan A., Trocha A., Bennett M.S., Ng H.L., Ali A., Brander C., and Yang O.O. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood 108 (2006) 3414-3419
3. Akari H., Arold S., Fukumori T., Okazaki T., Strebel K., and Adachi A. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74 (2000) 2907-2912
4. Ali A., Jamieson B.D., and Yang O.O. Half-genome human immunodeficiency virus type 1 constructs for rapid production of reporter viruses. J. Virol. Methods 110 (2003) 137-142
5. Ali A., Ng H.L., Dagarag M.D., and Yang O.O. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression. Eur. J. Immunol. 35 (2005) 3221-3228
6. Ali A., and Yang O.O. A novel small reporter gene and HIV-1 fitness assay. J. Virol. Methods 133 (2006) 41-47
7. Altes H.K., and Jansen V.A. Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1. Proc. R. Soc. Lond. B: Biol. Sci. 267 (2000) 183-189
8. Bandres J.C., Shaw A.S., and Ratner L. HIV-1 Nef protein downregulation of CD4 surface expression: relevance of the lck binding domain of CD4. Virology 207 (1995) 338-341
9. Burns J.C., Friedmann T., Driever W., Burrascano M., and Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8033-8037
10. Carl S., Greenough T.C., Krumbiegel M., Greenberg M., Skowronski J., Sullivan J.L., and Kirchhoff F. Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J. Virol. 75 (2001) 3657-3665
11. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., and Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10 (1999) 661-671
12. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., and Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 (1998) 397-401
13. Craig H.M., Pandori M.W., and Guatelli J.C. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11229-11234
14. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., and Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258 (1992) 1938-1941
15. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., Lawson V.A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J.S., Cunningham A., Dwyer D., Dowton D., and Mills J. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor, recipients. Science 270 (1995) 988-991
16. Du Z., Lang S.M., Sasseville V.G., Lackner A.A., Ilyinskii P.O., Daniel M.D., Jung J.U., and Desrosiers R.C. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82 (1995) 665-674
17. Dyer W.B., Geczy A.F., Kent S.J., McIntyre L.B., Blasdall S.A., Learmont J.C., and Sullivan J.S. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS 11 (1997) 1565-1574
18. Fackler O.T., and Baur A.S. Live and let die: Nef functions beyond HIV replication. Immunity 16 (2002) 493-497
19. Fujiwara M., and Takiguchi M. HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages. Blood 109 (2007) 4832-4838
20. Garcia J.V., and Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350 (1991) 508-511
21. Geffin R., Wolf D., Muller R., Hill M.D., Stellwag E., Freitag M., Sass G., Scott G.B., and Baur A.S. Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res. Hum. Retroviruses 16 (2000) 1855-1868
22. Gibbs J.S., Regier D.A., and Desrosiers R.C. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses 10 (1994) 343-350
23. Glushakova S., Grivel J.C., Suryanarayana K., Meylan P., Lifson J.D., Desrosiers R., and Margolis L. Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo. J. Virol. 73 (1999) 3968-3974
24. Jamieson B.D., and Zack J.A. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72 (1998) 6520-6526
25. Kestler III H.W., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 (1991) 651-662
26. Kirchhoff F., Easterbrook P.J., Douglas N., Troop M., Greenough T.C., Weber J., Carl S., Sullivan J.L., and Daniels R.S. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J. Virol. 73 (1999) 5497-5508
27. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 (1995) 228-232
28. Lama J., Mangasarian A., and Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9 (1999) 622-631
29. Lewis M.J., Balamurugan A., Ohno A., Kilpatrick S., Ng H.L., and Yang O.O. Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo. J. Immunol. 180 (2008) 4075-4081
30. Mangasarian A., Piguet V., Wang J.K., Chen Y.L., and Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 (1999) 1964-1973
31. Noviello C.M., Pond S.L., Lewis M.J., Richman D.D., Pillai S.K., Yang O.O., Little S.J., Smith D.M., and Guatelli J.C. Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1. J. Virol. 81 (2007) 4776-4786
32. Oelrichs R., Tsykin A., Rhodes D., Solomon A., Ellett A., McPhee D., and Deacon N. Genomic sequence of HIV type 1 from four members of the Sydney Blood Bank Cohort of long-term nonprogressors. AIDS Res. Hum. Retroviruses 14 (1998) 811-814
33. Pang S., Yu D., An D.S., Baldwin G.C., Xie Y., Poon B., Chow Y.H., Park N.H., and Chen I.S. Human immunodeficiency virus Env-independent infection of human CD4(-) cells. J. Virol. 74 (2000) 10994-11000
34. Piguet V., and Trono D. The Nef protein of primate lentiviruses. Rev. Med. Virol. 9 (1999) 111-120
35. Riggs N.L., Craig H.M., Pandori M.W., and Guatelli J.C. The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. Virology 258 (1999) 203-207
36. Salemi M., Lamers S.L., Yu S., de Oliveira T., Fitch W.M., and McGrath M.S. Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J. Virol. 79 (2005) 11343-11352
37. Salter R.D., Howell D.N., and Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21 (1985) 235-246
38. Schindler M., Munch J., Kutsch O., Li H., Santiago M.L., Bibollet-Ruche F., Muller-Trutwin M.C., Novembre F.J., Peeters M., Courgnaud V., Bailes E., Roques P., Sodora D.L., Silvestri G., Sharp P.M., Hahn B.H., and Kirchhoff F. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125 (2006) 1055-1067
39. Schwartz O., Marechal V., Le Gall S., Lemonnier F., and Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2 (1996) 338-342
40. Simmons A., Aluvihare V., and McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14 (2001) 763-777
41. Smith B.L., Krushelnycky B.W., Mochly-Rosen D., and Berg P. The HIV nef protein associates with protein kinase C theta. J. Biol. Chem. 271 (1996) 16753-16757
42. Swigut T., Alexander L., Morgan J., Lifson J., Mansfield K.G., Lang S., Johnson R.P., Skowronski J., and Desrosiers R. Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J. Virol. 78 (2004) 13335-13344
43. Tomiyama H., Akari H., Adachi A., and Takiguchi M. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production. J. Virol. 76 (2002) 7535-7543
44. Tomiyama H., Fujiwara M., Oka S., and Takiguchi M. Cutting edge: epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J. Immunol. 174 (2005) 36-40
45. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell 82 (1995) 189-192
46. Ueno T., Motozono C., Dohki S., Mwimanzi P., Rauch S., Fackler O.T., Oka S., and Takiguchi M. CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef. J. Immunol. 180 (2008) 1107-1116
47. Yang O.O., Nguyen P.T., Kalams S.A., Dorfman T., Gottlinger H.G., Stewart S., Chen I.S., Threlkeld S., and Walker B.D. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J. Virol. 76 (2002) 1626-1631